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The World Health Organization has launched a program to promote Global Cooperation 
on Assistive Technology (GATE). The objective of the GATE program is to improve 
access to high quality, affordable assistive technology for people with varying disabilities, 
diseases, and age-related conditions. As a first step, GATE has developed the assistive 
products list, a list of priority assistive products based on addressing the greatest need 
at population level. A specific group of people who can benefit from user appropriate 
assistive technology are people with intellectual disabilities. However, the use of assistive 
products by people with intellectual disabilities is a neglected area of research and practice, 
and offers considerable opportunities for the advancement of population health and the 
realization of basic human rights. It is unknown how many people with intellectual disabilities 
globally have access to appropriate assistive products and which factors influence their 
access. We call for a much greater focus on people with intellectual disabilities within 
the GATE program. We present a framework for understanding the complex interaction 
between intellectual disability, health and wellbeing, and assistive technology.
Keywords: intellectual disabilities, assistive technology, assistive devices, global health, public health policy, 
health inequality, World Health Organization
Only 10% of the people who are in need of assistive products actually have access to them, 
despite such access being claimed to be a human right (1, 2). An assistive product is any product 
(including devices, equipment, instruments, and software), either specially designed and produced 
or generally available, whose primary purpose is to maintain or improve an individual’s functioning 
and independence and thereby promote their wellbeing (3). Common examples of assistive prod-
ucts are spectacles, hearing aids, wheelchairs, prosthetics, communication boards, incontinence 
products, pill organizers, and therapeutic footwear. Assistive products can improve the quality 
of life for people with impairments, including the extent of their inclusion and participation in 
society. However, the use of assistive products by people with an intellectual disability (ID) is a 
neglected area of research and practice and offers considerable opportunities for the advancement 
of population health and the realization of basic human rights. About 1% of the total population 
have ID, with higher prevalence rates in low- and middle income countries (4). ID is defined 
by the American Association on Intellectual and Developmental Disabilities, the Diagnostic and 
Statistical Manual of Mental Disorders V, and the International Classifications of Diseases 10 
(mental retardation) as an IQ below 70, manifested during the developmental period (<18 years 
of age), with impairments in adaptive functioning, such as communication skills, social skills, 
personal independence, school, or work functioning (5–7).
The World Health Organization has launched a program to promote Global Cooperation on 
Assistive Technology (GATE) to implement those parts of the United Nations Convention on the 
Rights of Persons with Disabilities referring to assistive technology (3, 8, 9). The GATE program’s 
FiGure 1 | Factors related to the use of assistive technology by people with intellectual disabilities.
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objective is to improve access to high quality, affordable assis-
tive products for people with varying disabilities, diseases, and 
age-related conditions. As a first step, GATE has developed 
the assistive products list (APL) of priority assistive products 
to address the greatest needs at population level (10). To be 
effective, the APL will require countries to develop national 
assistive technology policies; source appropriate products; train 
specialized personnel; and develop effective and efficient systems 
of provision (10).
However, barriers that people with ID experience regarding 
access to assistive products have not yet been sufficiently con-
sidered. Worldwide, people with ID are still generally regarded 
as a devalued and stigmatized group, and at least part of their 
relatively poor health status is due to health inequities. People 
with ID are still often disadvantaged when attempting to access 
or secure health services and assistive products (11, 12). It is 
unknown what proportion of people with ID globally actually 
has access to appropriate assistive products. It has been suggested 
that for people with ID there is a high rate of underdiagnosis and 
misdiagnosis; so that too often they do not receive the correct 
treatment and that the need for rehabilitation arises as a result of 
absent or ineffective health care (13). The atypical presentation 
of symptoms by people with ID is often a challenge for their care 
system. With accurate assessment and appropriate interventions, 
the use of assistive products can be not only enabling and empow-
ering, but also transformative in facilitating new life skills and 
opportunities for people with ID.
Compared to the general population, people with ID have a 
higher prevalence of comorbidities which could be better man-
aged with assistive products (see Figure 1). For instance, motor 
disabilities are present in a significant proportion (26%) of people 
with ID (14). Visual impairment has a prevalence of 19.2% in adults 
with ID compared to 1.9% in adults of the general population. For 
hearing impairment, the prevalence is 30 vs 17%, respectively; and 
for dementia, it is 13.1 vs 5.4%, respectively (15). People with ID 
are now recognized as a group with a disproportionately greater 
need for assistive products due to higher rates of frailty and mul-
timorbidity (including increased severity and earlier onset) than 
the general population (16, 17). The result is a greater prevalence 
of disabilities in daily functioning and mobility with increased 
care needs and support required (18–20). Multimorbidity (the 
presence of two or more chronic conditions) is of particular 
concern with an 80% prevalence rate in adults >50 years with ID 
(17). Besides the association with age, multimorbidity, and frailty 
are also associated with a severe and profound level of ID (16, 17). 
The life expectancy of people with ID is increasing in line with 
the general population trends. Therefore, the prevalence of older 
people with ID is also likely to increase along with the demand for 
access to assistive products (21).
Access to assistive products presents three distinct challenges 
if people with ID are going to benefit from the increased provision 
aspired by GATE (see Figure 1). First, impairments in cognitive 
and adaptive functioning intrinsic to ID should be adequately 
catered for within population-level systems of assistive technology 
policy, products, health care personnel, caregivers, and provision. 
That means, communication skills and physical examinations by 
health care personnel need to be adapted to the intellectual and 
emotional level of the person with ID, to get the correct diagnosis 
and ensure the appropriate assistive product(s) are prescribed. 
The use of assistive products requires information, instruction, 
and support that are both accessible and understandable to the 
person with ID, if it is to be used effectively. In addition, a mul-
tidisciplinary approach to develop protocols for the training and 
support of people with ID is needed in order to direct the effective 
use and evaluation of the assistive products. For example, hearing 
aids require a customized habituation training program adjusted 
to an individual’s level of ID. This needs to be implemented in 
collaboration with the speech and language therapist, behaviorist, 
and caregiver together to help the person with ID to accept and 
benefit from the use of the new product.
A second challenge for people with ID to benefit from the APL 
is increased awareness among caregivers and health personnel 
of comorbidities that people with ID often experience; such as 
sensory impairments and dementia. These comorbidities may 
require the use of assistive products, and so the needs of the users 
with ID must be more often taken into account.
Third, people with ID will experience physical impairments 
not necessarily associated with ID, which are equally common 
in other sections of the population. For instance, a person with 
ID may need to learn to use a prosthesis or walking aids and—as 
above—the effective use of such products requires information, 
instruction, and support that is as accessible and understandable 
as possible. While it is known that the use of assistive products, 
such as a prosthesis, is influenced by a range of psychosocial 
factors, such research derives almost exclusively from users of 
assistive products without ID (22, 23).
Without a concerted and systematic approach to consider the 
challenges that ID presents, for the users, caregivers, and provid-
ers of assistive products, profound inequities in health, in life 
opportunities, and therefore in the quality of life for people with 
ID will persist. We call for a much greater focus on people with ID 
within the GATE program and in particular regarding national 
initiatives to adopt the APL.
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